Mary‐Claire Roghmann
-
- Antibiotic Use and Resistance 10
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 38
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 59
- Infection Control in Healthcare 20
- Clostridium difficile and Clostridium perfringens research 16
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 7
-
- Streptococcal Infections and Treatments 12
-
- Pressure Ulcer Prevention and Management 7
- Co-authors
- Anthony D. HarrisEli N. PerencevichJ. Kristie JohnsonDouglas D. BradhamSimone M. ShurlandMin ZhanJon P. FurunoPatricia Langenberg
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Mary‐Claire Roghmann
98 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 141
- Applied Microbiology and Biotechnology 464
- Clinical Biochemistry 1.0k
- Infectious Diseases 2.2k
- Molecular Medicine 458
- Critical Care and Intensive Care Medicine 384
Countries citing papers authored by Mary‐Claire Roghmann
This map shows the geographic impact of Mary‐Claire Roghmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary‐Claire Roghmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary‐Claire Roghmann more than expected).
Fields of papers citing papers by Mary‐Claire Roghmann
This network shows the impact of papers produced by Mary‐Claire Roghmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary‐Claire Roghmann. The network helps show where Mary‐Claire Roghmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary‐Claire Roghmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2020 | 1 | |
| 8 | 2018 | 11 | |
| 9 | 2015 | 49 | |
| 10 | 2013 | 1 | |
| 11 | 2011 | 36 | |
| 12 | 2011 | 16 | |
| 13 | 2010 | 2 | |
| 14 | 2006 | 45 | |
| 15 | 2006 | 52 | |
| 16 | 2005 | 33 | |
| 17 | 2005 | 3 | |
| 18 | 2002 | 46 | |
| 19 | 2002 | 32 | |
| 20 | 2002 | 16 |
About Mary‐Claire Roghmann
Mary‐Claire Roghmann is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 102 papers that have together received 3.8k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (59 papers), Bacterial Identification and Susceptibility Testing (38 papers), Infection Control in Healthcare (20 papers), Clostridium difficile and Clostridium perfringens research (16 papers), Streptococcal Infections and Treatments (12 papers), Antibiotic Use and Resistance (10 papers), Pressure Ulcer Prevention and Management (7 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (464 citations), Clinical Biochemistry (1.0k citations) and Infectious Diseases (2.2k citations). Mary‐Claire Roghmann has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Anthony D. Harris, Eli N. Perencevich, J. Kristie Johnson, Douglas D. Bradham, Simone M. Shurland, Min Zhan, Jon P. Furuno, Patricia Langenberg, Margaret McCusker and Alison D. Lydecker. Their work appears in journals such as Science, PLoS ONE and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.